The body composition effects of the amylin analogs in humans are unknown but there is animal evidence that they spare lean mass
Genetic restoration of heme oxygenase-1 expression protects from type 1 diabetes in NOD mice
J.PascoeW
The potential roles of exosomes in chronic obstructive pulmonary disease
The Tolerable Upper Intake Level (UL) established by the Food and Nutrition Board is 100 mg per day for adults
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 12 Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date Authors Pearson S , Kietsiriroje N , Ajjan RA Received 4 September 2019 Accepted for publication 8 November 2019 Published 2 December 2019 Volume 2019:12 Pages 25152529 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ming-Hui Zou Sam Pearson, 1, * Noppadol Kietsiriroje, 1, 2, * Ramzi A Ajjan 1 1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK
